Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
Ozempic, originally developed as a treatment for diabetes, has proven to be versatile, also treating obesity and promoting weight loss.
- Helping with weight loss
- Treating various other conditions
- Positive impact on weight-management, treating conditions associated with obesity
Now, a group of researchers claim that they’ve discovered a new usage for certain GLP-1 medications: stopping the aging process.
TruDiagnostic announced the results of a 32-week, double-blind, placebo-controlled trial that suggests Ozempic may reduce the user’s biologic age by just over three years.
Author's summary: Ozempic may reduce biological age.
More News
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups
- Sweden’s still ahead in the preparedness game — and now it means business
- How Johannesburg residents are protecting their power lines
- Apple says US passport digital IDs are coming to Wallet 'soon' | TechCrunch
- Justice unveils blueprint to cut remand population
- As top LDS Church leaders age, they move closer to ‘the zone of dementia’
- Venture Capital, Moonshots, and AI: The 2025 Tech Soap Opera